Ann: H1 2023 Preclinical and Clinical Programs Update, page-72

The non-interventional trial was always independent of the interventional trial. It was also never designed to show bisantrene-specific insights. The purpose of the trial was to collect critical control data needed to maximise the clinical and commercial value of the breast cancer bisantrene cardioprotection trial.

While there have always been external datasets that can answer some important questions (and these were used), there were other questions of critical importance that could not be answered using the historical datasets. I look forward to learning how these questions can now be answered from the historical datasets when the strategic update is released.